252 related articles for article (PubMed ID: 36804153)
1. Computed Tomography Radiomics to Differentiate Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma.
Mahmoudi S; Bernatz S; Ackermann J; Koch V; Dos Santos DP; Grünewald LD; Yel I; Martin SS; Scholtz JE; Stehle A; Walter D; Zeuzem S; Wild PJ; Vogl TJ; Kinzler MN
Clin Oncol (R Coll Radiol); 2023 May; 35(5):e312-e318. PubMed ID: 36804153
[TBL] [Abstract][Full Text] [Related]
2. Dual-energy CT based material decomposition to differentiate intrahepatic cholangiocarcinoma from hepatocellular carcinoma.
Mahmoudi S; Bernatz S; Althoff FC; Koch V; Grünewald LD; Scholtz JE; Walter D; Zeuzem S; Wild PJ; Vogl TJ; Kinzler MN
Eur J Radiol; 2022 Nov; 156():110556. PubMed ID: 36270195
[TBL] [Abstract][Full Text] [Related]
3. Classification of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma Based on Radiomic Analysis.
Xu X; Mao Y; Tang Y; Liu Y; Xue C; Yue Q; Liu Q; Wang J; Yin Y
Comput Math Methods Med; 2022; 2022():5334095. PubMed ID: 35237341
[TBL] [Abstract][Full Text] [Related]
4. Can machine learning radiomics provide pre-operative differentiation of combined hepatocellular cholangiocarcinoma from hepatocellular carcinoma and cholangiocarcinoma to inform optimal treatment planning?
Liu X; Khalvati F; Namdar K; Fischer S; Lewis S; Taouli B; Haider MA; Jhaveri KS
Eur Radiol; 2021 Jan; 31(1):244-255. PubMed ID: 32749585
[TBL] [Abstract][Full Text] [Related]
5. DCE-MRI based radiomics nomogram for preoperatively differentiating combined hepatocellular-cholangiocarcinoma from mass-forming intrahepatic cholangiocarcinoma.
Zhou Y; Zhou G; Zhang J; Xu C; Zhu F; Xu P
Eur Radiol; 2022 Jul; 32(7):5004-5015. PubMed ID: 35128572
[TBL] [Abstract][Full Text] [Related]
6. The Application Value of MRI T2
Huang F; Liu X; Liu P; Xu D; Li Z; Lin H; Xie A
Comput Math Methods Med; 2022; 2022():7099476. PubMed ID: 36203532
[TBL] [Abstract][Full Text] [Related]
7. Distinguishing intrahepatic mass-forming biliary carcinomas from hepatocellular carcinoma by computed tomography and magnetic resonance imaging using the Bayesian method: a bi-center study.
Ichikawa S; Isoda H; Shimizu T; Tamada D; Taura K; Togashi K; Onishi H; Motosugi U
Eur Radiol; 2020 Nov; 30(11):5992-6002. PubMed ID: 32500195
[TBL] [Abstract][Full Text] [Related]
8. A machine-learning model based on dynamic contrast-enhanced MRI for preoperative differentiation between hepatocellular carcinoma and combined hepatocellular-cholangiocarcinoma.
Deng X; Liao Z
Clin Radiol; 2024 Jun; 79(6):e817-e825. PubMed ID: 38413354
[TBL] [Abstract][Full Text] [Related]
9. Differential diagnosis of hepatocellular carcinoma and intrahepatic cholangiocarcinoma based on spatial and channel attention mechanisms.
Huang JL; Sun Y; Wu ZH; Zhu HJ; Xia GJ; Zhu XS; Wu JH; Zhang KH
J Cancer Res Clin Oncol; 2023 Sep; 149(12):10161-10168. PubMed ID: 37268850
[TBL] [Abstract][Full Text] [Related]
10. Differentiation of mass-forming intrahepatic cholangiocarcinoma from poorly differentiated hepatocellular carcinoma: based on the multivariate analysis of contrast-enhanced computed tomography findings.
Zhao YJ; Chen WX; Wu DS; Zhang WY; Zheng LR
Abdom Radiol (NY); 2016 May; 41(5):978-89. PubMed ID: 27193795
[TBL] [Abstract][Full Text] [Related]
11. MRI for Hepatitis B-Associated Intrahepatic Cholangiocarcinoma: A Multicenter Comparative Study.
Sheng R; Wang H; Zhang Y; Sun W; Jin K; Dai Y; Zhang W; Zeng M; Zhou J
J Magn Reson Imaging; 2024 Mar; 59(3):1093-1104. PubMed ID: 37309823
[TBL] [Abstract][Full Text] [Related]
12. Implications of ultrasound-based deep learning model for preoperatively differentiating combined hepatocellular-cholangiocarcinoma from hepatocellular carcinoma and intrahepatic cholangiocarcinoma.
Chen J; Zhang W; Bao J; Wang K; Zhao Q; Zhu Y; Chen Y
Abdom Radiol (NY); 2024 Jan; 49(1):93-102. PubMed ID: 37999743
[TBL] [Abstract][Full Text] [Related]
13. Preoperative prediction for pathological grade of hepatocellular carcinoma via machine learning-based radiomics.
Mao B; Zhang L; Ning P; Ding F; Wu F; Lu G; Geng Y; Ma J
Eur Radiol; 2020 Dec; 30(12):6924-6932. PubMed ID: 32696256
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive radiomics nomogram for predicting survival of patients with combined hepatocellular carcinoma and cholangiocarcinoma.
Tang YY; Zhao YN; Zhang T; Chen ZY; Ma XL
World J Gastroenterol; 2021 Nov; 27(41):7173-7189. PubMed ID: 34887636
[TBL] [Abstract][Full Text] [Related]
15. Added-value of ancillary imaging features for differentiating hepatocellular carcinoma from intrahepatic mass-forming cholangiocarcinoma on Gd-BOPTA-enhanced MRI in LI-RADS M.
Zheng W; Huang H; She D; Xiong M; Chen X; Lin X; Cao D
Abdom Radiol (NY); 2022 Mar; 47(3):957-968. PubMed ID: 34964069
[TBL] [Abstract][Full Text] [Related]
16. LI-RADS-CEUS - Proposal for a Contrast-Enhanced Ultrasound Algorithm for the Diagnosis of Hepatocellular Carcinoma in High-Risk Populations.
Schellhaas B; Wildner D; Pfeifer L; Goertz RS; Hagel A; Neurath MF; Strobel D
Ultraschall Med; 2016 Dec; 37(6):627-634. PubMed ID: 27486793
[No Abstract] [Full Text] [Related]
17. Predicting very early recurrence in intrahepatic cholangiocarcinoma after curative hepatectomy using machine learning radiomics based on CECT: A multi-institutional study.
Chen B; Mao Y; Li J; Zhao Z; Chen Q; Yu Y; Yang Y; Dong Y; Lin G; Yao J; Lu M; Wu L; Bo Z; Chen G; Xie X
Comput Biol Med; 2023 Dec; 167():107612. PubMed ID: 37939408
[TBL] [Abstract][Full Text] [Related]
18. Differentiation of intrahepatic cholangiocarcinoma from hepatocellular carcinoma in high-risk patients: A predictive model using contrast-enhanced ultrasound.
Chen LD; Ruan SM; Liang JY; Yang Z; Shen SL; Huang Y; Li W; Wang Z; Xie XY; Lu MD; Kuang M; Wang W
World J Gastroenterol; 2018 Sep; 24(33):3786-3798. PubMed ID: 30197484
[TBL] [Abstract][Full Text] [Related]
19. Combined hepatocellular and cholangiocarcinoma: correlation between CT findings and clinicopathological features.
Fukukura Y; Taguchi J; Nakashima O; Wada Y; Kojiro M
J Comput Assist Tomogr; 1997; 21(1):52-8. PubMed ID: 9022770
[TBL] [Abstract][Full Text] [Related]
20. Distinguishing intrahepatic cholangiocarcinoma from hepatocellular carcinoma in patients with and without risks: the evaluation of the LR-M criteria of contrast-enhanced ultrasound liver imaging reporting and data system version 2017.
Li F; Li Q; Liu Y; Han J; Zheng W; Huang Y; Zheng X; Cao L; Zhou JH
Eur Radiol; 2020 Jan; 30(1):461-470. PubMed ID: 31297632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
